Trump set to reveal MFN pricing deals with mid-sized companies: report

The Trump administration looks set to unveil a new slate of most favored nation (MFN) drug pricing deals with several mid-sized biopharma companies, according to Bloomberg. | The Trump administration will soon unveil most favored nation drug pricing deals with several mid-sized biopharma companies, according to a report from Bloomberg. The announcement is expected on Monday.